These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27165201)

  • 1. Factors Predicting Fecal Occult Blood Testing among Residents of Bushehr, Iran, Based on the Health Belief Model.
    Ghobadi Dashdebi K; Noroozi A; Tahmasebi R
    Asian Pac J Cancer Prev; 2016; 17(S3):17-22. PubMed ID: 27165201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Educational Intervention Based on Health Belief Model and Social Support on the Rate of Participation of Individuals in Performing Fecal Occult Blood Test for Colorectal Cancer Screening.
    Gholampour Y; Jaderipour A; Khani Jeihooni A; Kashfi SM; Afzali Harsini P
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2777-2787. PubMed ID: 30360606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Colorectal Cancer Screening Participation in Southern Khorasan (Iran).
    Ramazani AA; Norozi E; AmirabadiZadeh H; Ehteshampour AR; Salehiniya H
    J Gastrointest Cancer; 2021 Mar; 52(1):187-191. PubMed ID: 32125621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing colonoscopy behaviour among Koreans with a positive faecal occult blood tests.
    Choi E; Jeon J; Kim J
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e13008. PubMed ID: 30748048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with adherence to fecal occult blood testing for colorectal cancer screening among adults in the Republic of Korea.
    Bae N; Park S; Lim S
    Eur J Oncol Nurs; 2014 Feb; 18(1):72-7. PubMed ID: 24183583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do benefits and barriers differ by stage of adoption for colorectal cancer screening?
    Rawl SM; Menon U; Champion VL; May FE; Loehrer P; Hunter C; Azzouz F; Monahan PO; Skinner CS
    Health Educ Res; 2005 Apr; 20(2):137-48. PubMed ID: 15314036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with intentions to adhere to colorectal cancer screening follow-up exams.
    Zheng YF; Saito T; Takahashi M; Ishibashi T; Kai I
    BMC Public Health; 2006 Nov; 6():272. PubMed ID: 17083746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison between application of fecal occult blood quantitive testing instrument and colloidal gold strip method in colorectal cancer screening].
    Huang YQ; Zhang MW; Shen YZ; Ma HQ; Cai SR; Zhang SZ; Zheng S
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Aug; 47(8):747-51. PubMed ID: 24246083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal occult blood screening in the Minnesota study: role of chance detection of lesions.
    Ederer F; Church TR; Mandel JS
    J Natl Cancer Inst; 1997 Oct; 89(19):1423-8. PubMed ID: 9326911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beliefs associated with fecal occult blood test and colonoscopy use at a worksite colon cancer screening program.
    Menon U; Champion VL; Larkin GN; Zollinger TW; Gerde PM; Vernon SW
    J Occup Environ Med; 2003 Aug; 45(8):891-8. PubMed ID: 12915791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Likelihood of a fecal occult blood test uptake among older adults: comparisons between health professionals and healthcare volunteers based on the health belief model.
    Lin TY; Chuang ST; Huang SF; Hsu HP; Lu LT; Guo JL
    BMC Geriatr; 2019 Feb; 19(1):51. PubMed ID: 30791892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.
    Winawer SJ; Flehinger BJ; Schottenfeld D; Miller DG
    J Natl Cancer Inst; 1993 Aug; 85(16):1311-8. PubMed ID: 8340943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public awareness of colorectal cancer in a Turkish population: importance of fecal occult blood testing.
    Bas K; Guler T; Gunay LM; Besim H; Uygur D
    Asian Pac J Cancer Prev; 2012; 13(1):195-8. PubMed ID: 22502667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening preferences for colorectal cancer: a patient demographic study.
    Sheikh RA; Kapre S; Calof OM; Ward C; Raina A
    South Med J; 2004 Mar; 97(3):224-30. PubMed ID: 15043327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
    Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
    Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.